Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine technologies: view to the future

N R Rabinovich1, P McInnes, D L Klein

  • 1Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20982-9902.

Science (New York, N.Y.)
|September 2, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IMMUNITY AND SUSCEPTIBILITY AFTER DIPHTHERIA.

Canadian Medical Association journal·2010
Same author

THE PRACTICAL APPLICATION AND INTERPRETATION OF THE SCHICK TEST: THE DIPHTHERIA ANTITOXIN CONTENT OF THE BLOOD OF THE SHICK-NEGATIVE REACTOR.

Canadian Medical Association journal·2010
Same author

The Term "Dromedary Onset" of Infantile Paralysis, a Misleading One.

Canadian Medical Association journal·2010
Same author

Oxycephaly, with the Report of Two Cases in a Brother and Sister.

Canadian Medical Association journal·2010
Same author

Meningococcus Infection Treated With sulfonamide Drugs.

Canadian Medical Association journal·2010
Same author

Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.

The Pediatric infectious disease journal·2001
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

New vaccine technologies leverage advances in basic science for rational design. Understanding microbial virulence and immune responses enables next-generation vaccines against infectious diseases.

Area of Science:

  • Biomedical Science
  • Immunology
  • Microbiology

Background:

  • Vaccine development is a cornerstone of public health, significantly reducing infectious disease burden.
  • Traditional vaccine approaches have limitations in addressing emerging and persistent infectious agents.

Purpose of the Study:

  • To summarize the current status and future directions of novel vaccine technologies.
  • To highlight the impact of recent scientific advances on vaccine design.

Main Methods:

  • Review of recent advances in understanding microbial virulence factors.
  • Analysis of the host immune response mechanisms to infection.
  • Synthesis of information on emerging vaccine platforms and rational design principles.

Related Experiment Videos

Main Results:

  • Improved understanding of pathogen-host interactions is crucial for vaccine development.
  • Rational design approaches are enabling the creation of more effective and targeted vaccines.
  • New vaccine technologies offer promising strategies against a range of infectious diseases.

Conclusions:

  • Advances in basic sciences are revolutionizing vaccine development.
  • Next-generation vaccines based on rational design hold significant potential for controlling infectious diseases.